Brief: Forward Pharma Gets Notice From Biogen Units

Forward Pharma A/S

26/03/2019 22:33

March 26 (Reuters) - Forward Pharma:
    * FORWARD PHARMA -  NOTICE FROM 2 BIOGEN UNITS PARTY TO JAN
17,
2017 LICENSE AGREEMENT OF EXERCISE OF OPTION TO PURCHASE IP IN
U.S. ASSOCIATED WITH CO
    * FORWARD PHARMA -   BIOGEN HAS ASSUMED OWNERSHIP AND
RESPONSIBILITY FOR THE ASSIGNED U.S. INTELLECTUAL PROPERTY - SEC
FILING

Source text: (http://bit.ly/2WpaUB2)
Further company coverage:  BIIB.O 

 ((Reuters.Briefs@thomsonreuters.com;))